Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-21-026392

EVP, Research & CSO acquired 14,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Virgin Herbert EVP, Research & CSO 2021-04-09 Option exercise +14,000 $1.53 $21,420 88,200 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Virgin Herbert EVP, Research & CSO 2021-04-09 Option exercise · Stock Option (Right to Buy) −14,000 323,555 D: show line 2 in the form
Loading xslF345X03/doc4.xml…